|
|
Liver Cancer, HBV and Aflatoxin
Biomarkers
This study, started in 1993, is composed of 3 projects on molecular
biomarkers for environmental carcinogens.
OCT
The Oltipraz Chemoprevention Trial is a Phase II randomized clinical trial
designed to evaluate weekly and daily administrations of oltipraz for
reducing urinary and/or serum aflatoxin biomarkers compared to placebo.
Funding provided by the National Institute of Environmental Health Sciences
and the National Cancer Institute.
This page was last updated
October 2001.
| |
|
